Document is current
Any future updates will be listed below
-
Authors
Lindholm, Päivi https://orcid.org/0000-0003-3022-5035
Saarma, Mart https://orcid.org/0000-0001-5543-7160
-
Funding
Funding for this research was provided by:
Academy of Finland (1310891)
Jane ja Aatos Erkon Säätiö
- License Information
-
More Information
Article History
Received: 14 June 2021
Revised: 9 November 2021
Accepted: 15 November 2021
First Online: 14 December 2021
Competing interests
: P.L. and M.S. are inventors in the CDNF- and MANF-related patents (7,452,969; 9,592,270) owned by Herantis Pharma Plc. M.S. is a minority shareholder in Herantis Pharma Plc. Intellectual property concerning CDNF fragments belongs to the University of Helsinki.
